Established in 2015, Aziyo Biologics is a privately-held, commercially-oriented biotech company focused on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties
Since its founding, the Company has expanded through a combination of acquisitions and strategic partnerships, creating a high-growth commercial entity. Our mission is to restore health and mobility through the development of innovative new solutions that expand the possibilities of regenerative medicine.